AP486A - Indole derivatives. - Google Patents

Indole derivatives. Download PDF

Info

Publication number
AP486A
AP486A APAP/P/1994/000633A AP9400633A AP486A AP 486 A AP486 A AP 486A AP 9400633 A AP9400633 A AP 9400633A AP 486 A AP486 A AP 486A
Authority
AP
ARIPO
Prior art keywords
treating
indole
methylaminosulfonylmethyl
ranging
amount
Prior art date
Application number
APAP/P/1994/000633A
Other languages
English (en)
Other versions
AP9400633A0 (en
Inventor
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9400633A0 publication Critical patent/AP9400633A0/xx
Application granted granted Critical
Publication of AP486A publication Critical patent/AP486A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
APAP/P/1994/000633A 1993-04-27 1994-04-07 Indole derivatives. AP486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5393093A 1993-04-27 1993-04-27

Publications (2)

Publication Number Publication Date
AP9400633A0 AP9400633A0 (en) 1994-04-30
AP486A true AP486A (en) 1996-04-16

Family

ID=21987528

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000633A AP486A (en) 1993-04-27 1994-04-07 Indole derivatives.

Country Status (29)

Country Link
EP (1) EP0696194B1 (es)
JP (1) JP2922307B2 (es)
KR (1) KR960701636A (es)
CN (3) CN1121689A (es)
AP (1) AP486A (es)
AT (1) ATE222492T1 (es)
AU (1) AU689469B2 (es)
BG (1) BG61898B1 (es)
BR (1) BR9406435A (es)
CA (1) CA2161533C (es)
CO (1) CO4230093A1 (es)
CZ (1) CZ290416B6 (es)
DE (1) DE69431201T2 (es)
DK (1) DK0696194T3 (es)
ES (1) ES2180573T3 (es)
HU (1) HU222488B1 (es)
IL (1) IL109376A (es)
MX (1) MX9403088A (es)
NO (1) NO308236B1 (es)
NZ (1) NZ263614A (es)
OA (1) OA10189A (es)
PL (1) PL175156B1 (es)
PT (1) PT696194E (es)
RO (1) RO117760B1 (es)
RU (1) RU2132683C1 (es)
SG (1) SG43951A1 (es)
SK (1) SK283353B6 (es)
WO (1) WO1994025023A1 (es)
ZA (1) ZA942805B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
KR100191973B1 (ko) * 1993-08-31 1999-06-15 디. 제이. 우드, 스피겔 알렌 제이 5-아릴인돌 유도체
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
WO1996011923A1 (en) * 1994-10-12 1996-04-25 Pfizer Limited Indole derivative for the treatment of migraine
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
MX2022009528A (es) * 2020-02-04 2022-11-14 Mindset Pharma Inc Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives

Also Published As

Publication number Publication date
PL311266A1 (en) 1996-02-05
EP0696194A1 (en) 1996-02-14
CZ290416B6 (cs) 2002-07-17
CN1121689A (zh) 1996-05-01
ATE222492T1 (de) 2002-09-15
AU6436094A (en) 1994-11-21
HU222488B1 (hu) 2003-07-28
KR960701636A (ko) 1996-03-28
PT696194E (pt) 2002-11-29
CA2161533A1 (en) 1994-11-10
BR9406435A (pt) 1996-01-09
JPH08504829A (ja) 1996-05-28
EP0696194B1 (en) 2002-08-21
NZ263614A (en) 1998-02-26
ZA942805B (en) 1995-10-23
CN1509713A (zh) 2004-07-07
DE69431201T2 (de) 2002-12-05
AP9400633A0 (en) 1994-04-30
CN1515252A (zh) 2004-07-28
BG100093A (bg) 1996-04-30
HU9503089D0 (en) 1995-12-28
OA10189A (en) 1996-12-18
HUT73670A (en) 1996-09-30
SK133295A3 (en) 1997-01-08
RO117760B1 (ro) 2002-07-30
CZ9502802A3 (en) 1996-04-17
IL109376A (en) 2000-10-31
SK283353B6 (sk) 2003-06-03
NO954287L (no) 1995-10-26
IL109376A0 (en) 1994-07-31
PL175156B1 (pl) 1998-11-30
DK0696194T3 (da) 2002-10-07
SG43951A1 (en) 1997-11-14
AU689469B2 (en) 1998-04-02
MX9403088A (es) 1997-02-28
BG61898B1 (bg) 1998-09-30
CA2161533C (en) 1998-08-04
CO4230093A1 (es) 1995-10-19
JP2922307B2 (ja) 1999-07-19
NO308236B1 (no) 2000-08-21
RU2132683C1 (ru) 1999-07-10
NO954287D0 (no) 1995-10-26
WO1994025023A1 (en) 1994-11-10
DE69431201D1 (de) 2002-09-26
ES2180573T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
AP486A (en) Indole derivatives.
US6512002B2 (en) Methods of treatment for premature ejaculation in a male
WO1994025023A9 (en) Use of indole derivatives as 5ht1 antagonists
JPH09508137A (ja) セロトニンアゴニストおよびアンタゴニストとしての4−インドール誘導体
IL87658A (en) Tetrahydro-H-) -12-imidazolylmethyl (pyrido-) and azapino- (] B) -4,3 ([indole-1-ointments, their preparation and pharmaceutical preparations containing them
JPH02167280A (ja) ラクタム誘導体
WO1998027089A1 (en) 5-alkyl indole compounds as 5-ht1d-like ligands
AU627769B2 (en) The use of lactam derivatives in the treatment of cognitive disorders
CA2213241C (en) Indole derivative for the treatment of migraine
JPS6335570A (ja) ヘテロ環式化合物
AU627770B2 (en) The use of lactam derivatives in the treatment of depression
US5945118A (en) Indole derivative for the treatment of migraine
US5229407A (en) Medicaments
US5221687A (en) Medicaments
JPH02180823A (ja) 医薬
US5276050A (en) Medicaments
EP0411901A2 (en) Treatment of conditions involving excessive eating